Back to
SC US (TTGP), LTD.
QNCX10 quarters
Position history for
SC US (TTGP), LTD.'s holdings in QUINCE THERAPEUTICS INC
No. SC US (TTGP) exited its QNCX (Quince Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 560,594 shares worth $29.7M. SC US (TTGP) first reported QNCX in Q2 2019 and held it in 9 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$44.2M
Total Shares Change
-1M
Quarter-by-Quarter History
Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors